New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020-PR Newswire APAC

ADELAIDE, Australia, Oct. 26, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that new clinical data has been presented on TOLSURA® (SUBA®-itraconazole) at IDWeek 2020, being held virtually in the US from October 21st-25th. The conference is attended by over 11,500 doctors and other healthcare...

Read more: New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020-PR Newswire APAC

More Articles …

  1. TerraPay strengthens its entry in North America with FINTRAC Canada MSB License-PR Newswire APAC
  2. Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies-PR Newswire APAC
  3. Zayed Award for Human Fraternity Judging Committee meets with Pope-PR Newswire APAC
  4. Azura Ophthalmics raises $28m for registration studies for treatment of leading cause of dry eye disease-PR Newswire APAC
  5. Ferguson Hyams Multi-Strategy Fund (FHMSF) Added to Quilter and Clearstream Platforms-PR Newswire APAC
  6. The digital Valmont Barcelona Bridal Fashion Week revitalises the bridal fashion industry-PR Newswire APAC
  7. New Blis report pinpoints geography, mobility and psychology as the key factors impacting behaviour change leading up to the holiday season
  8. Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification-PR Newswire APAC
  9. International Recognition for CERTIS' COVID-19 Campaign in Singapore-PR Newswire APAC
  10. Really Simple Systems Launches New Easy-to-Use Marketing Tool-PR Newswire APAC